Core Viewpoint - United Chemical announced an investment of 120 million yuan in Zhuoguangrui Technology, acquiring a 19.3548% stake, with a pre-investment valuation of 500 million yuan. The investment aims to support the development of domestic projection exposure machines and related components, which are considered essential for the digital economy and AI industries [1][2]. Group 1: Financial Performance of Zhuoguangrui - Zhuoguangrui reported zero revenue for the first five months of this year and a loss exceeding 25 million yuan. As of May 31, its net assets were -41.47 million yuan [1][2]. - For the year 2024, Zhuoguangrui is projected to achieve revenue of 26.58 million yuan but will incur a loss of 15.84 million yuan. These financial figures are unaudited and based on simulated data [2][3]. Group 2: Company Background and Operations - Zhuoguangrui was established on March 7, 2023, and is primarily focused on the research and development of projection exposure machines used in semiconductor wafer manufacturing [2][4]. - The company has a wholly-owned subsidiary, Gangjing Optical Technology, founded on June 2, 2023, which specializes in the R&D, production, and sales of optical components for projection exposure machines [3][4]. Group 3: Investment Purpose and Strategic Direction - The investment funds will be specifically allocated for the R&D of projection exposure machines and related components, with a maximum of 20% of the investment directed towards Gangjing Optical Technology [5]. - United Chemical views this investment as a strategic pivot towards becoming a technology-driven company, moving away from traditional manufacturing [6]. Group 4: Market Performance and Future Outlook - United Chemical's stock price increased by 308% from April 1 to July 7, 2025, and 438% in the first half of the year, making it a significant focus in the capital market [6][7]. - The company has decided to postpone two major fundraising projects due to low investment progress, indicating a shift in focus towards semiconductor-related initiatives [7].
上半年涨逾400%的联合化学，拟1.2亿元投向半导体投影式曝光机研究 标的净资产-4100万元，估值5亿元